Accelerate the Commercialization of Precision Medicine for Rare Diseases
With up to 95% of target patient populations undiagnosed or misdiagnosed, the conventional commercial operations playbook doesn't work for rare and specialty conditions. The result: 59% of products miss peak sales timelines.
Enter IPM.ai
Through ML/AI, we transform real world data into real world insights to uncover the ideal patient and their healthcare ecosystem and accelerate the commercialization of lifesaving therapies.
